Teva Pharmaceutical Industries Ltd. is buying Auspex Pharmaceuticals Inc. for about $3.2 billion in a move to strengthen its position on central nervous system condition treatments. … Click to Continue »
Living articles about food home & travel from in Kansas City, MO | KansasCity.com, Kansas City Star: Living
Mon, 03/30/2015 - 5:16am